Journal
European heart journal
Publication Date
5-14-2025
Volume
46
Issue
19
First Page
1863
Last Page
1866
Document Type
Open Access Publication
DOI
10.1093/eurheartj/ehaf062
Rights and Permissions
Mahmoud Abdellatif, Francisco Vasques-Nóvoa, Viktoria Trummer-Herbst, Sylvère Durand, Franziska Koser, Moydul Islam, Jihoon Nah, Eun-Ah Sung, Ruli Feng, Fanny Aprahamian, Andreas Prokesch, Pablo Zardoya-Laguardia, Junichi Sadoshima, Abhinav Diwan, Wolfgang A Linke, João Pedro Ferreira, Guido Kroemer, Simon Sedej, Autophagy is required for the therapeutic effects of the NAD+ precursor nicotinamide in obesity-related heart failure with preserved ejection fraction, European Heart Journal, Volume 46, Issue 19, 14 May 2025, Pages 1863–1866, https://doi.org/10.1093/eurheartj/ehaf062. https://academic.oup.com/eurheartj/article/46/19/1863/8041827?login=true#google_vignette. © The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
Recommended Citation
Abdellatif, Mahmoud; Islam, Moydul; Diwan, Abhinav; and et al., "Autophagy is required for the therapeutic effects of the NAD+ precursor nicotinamide in obesity-related heart failure with preserved ejection fraction." European heart journal. 46, 19. 1863 - 1866. (2025).
https://digitalcommons.wustl.edu/oa_4/5098
Department
ICTS (Institute of Clinical and Translational Sciences)
